Original Research
Published on 13 Feb 2026
Deep learning-based assessment of PD-L1 expression in NSCLC predicts outcome for patients treated with anti-PD-1 immunotherapy
in Cancer Immunity and Immunotherapy
- 238 views
Original Research
Published on 13 Feb 2026
in Cancer Immunity and Immunotherapy
Original Research
Published on 13 Feb 2026
in Cancer Immunity and Immunotherapy
Original Research
Published on 13 Feb 2026
in Microbial Immunology
Original Research
Published on 13 Feb 2026
in Vaccines and Molecular Therapeutics
Systematic Review
Published on 13 Feb 2026
in Alloimmunity and Transplantation
Original Research
Accepted on 12 Feb 2026
in Cancer Immunity and Immunotherapy
Case Report
Accepted on 12 Feb 2026
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Accepted on 12 Feb 2026
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 12 Feb 2026
in Cancer Immunity and Immunotherapy
Review
Accepted on 12 Feb 2026
in Cancer Immunity and Immunotherapy
Review
Accepted on 12 Feb 2026
in Cancer Immunity and Immunotherapy
Case Report
Accepted on 12 Feb 2026
in Cancer Immunity and Immunotherapy
Case Report
Accepted on 12 Feb 2026
in Primary Immunodeficiencies
Original Research
Accepted on 12 Feb 2026
in Vaccines and Molecular Therapeutics
Correction
Accepted on 12 Feb 2026
in Immunological Tolerance and Regulation
Review
Accepted on 12 Feb 2026
in Vaccines and Molecular Therapeutics
Original Research
Accepted on 12 Feb 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 12 Feb 2026
in Inflammation
Review
Accepted on 12 Feb 2026
in Inflammation
Original Research
Accepted on 12 Feb 2026
in Inflammation
Original Research
Accepted on 12 Feb 2026
in T Cell Biology
Original Research
Accepted on 12 Feb 2026
in Cancer Immunity and Immunotherapy
Review
Accepted on 12 Feb 2026
in Inflammation
Systematic Review
Accepted on 12 Feb 2026
in Cancer Immunity and Immunotherapy